表紙
市場調查報告書
商品編碼
1028192

骨癌治療藥的全球市場(2021年∼2025年)

Global Bone Cancer Drugs Market 2021-2025

出版日期: | 出版商: TechNavio (Infiniti Research Ltd.) | 英文 120 Pages | 訂單完成後即時交付

價格
  • 全貌
  • 簡介
  • 目錄
簡介

骨癌治療藥的市場規模在2021年∼2025年的預測期間內,預計將以5.46%的年複合成長率推移,並成長到9億9,669萬美元。

本報告提供骨癌治療藥市場相關之本報告提供整體分析,市場規模與預測,趨勢,涵括成長要素,課題,以及約25位供應商的供應商分析。

該市場成長的主要因素有青年人骨癌的高盛行率,以及風險要素的增加。

本報告提供骨癌治療藥市場調查,提供市場概要,市場規模,市場預測,客戶形勢,各適應症·各地區的分析,再加上業者情勢和供應商分析等資訊。

目錄

摘要整理

市場形勢

  • 市場生態系統
  • 價值鏈分析

市場規模

  • 市場定義
  • 市場區隔分析
  • 市場規模:2020年
  • 市場預測:從2020年∼2025年的預測

波特的五力分析

  • 買方議價能力
  • 供給企業談判力
  • 新加入廠商業者的威脅
  • 替代品的威脅
  • 競爭的威脅
  • 市場情況

各適應症市場區隔

  • 市場區隔
  • 各適應症比較
  • 骨癌:市場規模與預測(2020年∼2025年)
  • 伊文氏肉瘤:市場規模與預測(2020年∼2025年)
  • 軟骨肉瘤:市場規模與預測(2020年∼2025年)
  • 其他骨癌症:市場規模與預測(2020年∼2025年)
  • 各適應症市場機會

客戶形勢

  • 客戶形勢

各地區形勢

  • 各地區市場區隔
  • 各地區比較
  • 北美:市場規模與預測(2020年∼2025年)
  • 歐洲:市場規模與預測(2020年∼2025年)
  • 亞洲:市場規模與預測(2020年∼2025年)
  • 其他地區:市場規模與預測(2020年∼2025年)
  • 主要國家
  • 各地區形勢市場機會
  • 市場成長促進因素
  • 市場課題
  • 市場趨勢

業者情勢

  • 概要
  • 創造性破壞狀況

供應商分析

  • 交易廠商
  • 供應商的市場定位
  • Amgen Inc.
  • Baxter International Inc.
  • Bayer AG
  • Bristol-Myers Squibb Co.
  • Eisai Co. Ltd.
  • F. Hoffmann-La Roche Ltd.
  • Merck and Co. Inc.
  • Novartis AG
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.

附錄

目錄
Product Code: IRTNTR45676

Technavio has been monitoring the bone cancer drugs market and it is poised to grow by USD 996.69 mn during 2021-2025, progressing at a CAGR of 5.46% during the forecast period. Our report on the bone cancer drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by strong prevalence of osteosarcoma in younger patients and growing risk factors. In addition, strong prevalence of osteosarcoma in younger patients is anticipated to boost the growth of the market as well.

The bone cancer drugs market analysis includes the indication segment and geographic landscape.

Technavio's bone cancer drugs market is segmented as below:

By Indication

  • Osteosarcoma
  • Ewing's sarcoma
  • Chondrosarcoma
  • Other bone cancers

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • ROW

This study identifies the increasing strategic alliances as one of the prime reasons driving the bone cancer drugs market growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on bone cancer drugs market covers the following areas:

  • Bone cancer drugs market sizing
  • Bone cancer drugs market forecast
  • Bone cancer drugs market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading bone cancer drugs market vendors that include Amgen Inc., Baxter International Inc., Bayer AG, Bristol-Myers Squibb Co., Eisai Co. Ltd., F. Hoffmann-La Roche Ltd., Merck and Co. Inc., Novartis AG, Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd. Also, the bone cancer drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

  • Executive Summary
    • Market overview
  • Market Landscape
    • Market ecosystem
    • Value chain analysis
  • Market Sizing
    • Market definition
    • Market segment analysis
    • Market size 2020
    • Market outlook: Forecast for 2020 - 2025
  • Five Forces Analysis
    • Bargaining power of buyers
    • Bargaining power of suppliers
    • Threat of new entrants
    • Threat of substitutes
    • Threat of rivalry
    • Market condition
  • Market Segmentation by Indication
    • Market segments
    • Comparison by Indication
    • Osteosarcoma - Market size and forecast 2020-2025
    • Ewing's sarcoma - Market size and forecast 2020-2025
    • Chondrosarcoma - Market size and forecast 2020-2025
    • Other bone cancers - Market size and forecast 2020-2025
    • Market opportunity by Indication
  • Customer landscape
    • Customer landscape
  • Geographic Landscape
    • Geographic segmentation
    • Geographic comparison
    • North America - Market size and forecast 2020-2025
    • Europe - Market size and forecast 2020-2025
    • Asia - Market size and forecast 2020-2025
    • ROW - Market size and forecast 2020-2025
    • Key leading countries
    • Market opportunity By Geographical Landscape
    • Market drivers
    • Market challenges
    • Market trends
  • Vendor Landscape
    • Overview
    • Landscape disruption
  • Vendor Analysis
    • Vendors covered
    • Market positioning of vendors
    • Amgen Inc.
    • Baxter International Inc.
    • Bayer AG
    • Bristol-Myers Squibb Co.
    • Eisai Co. Ltd.
    • F. Hoffmann-La Roche Ltd.
    • Merck and Co. Inc.
    • Novartis AG
    • Sun Pharmaceutical Industries Ltd.
    • Teva Pharmaceutical Industries Ltd.
  • Appendix
    • Scope of the report
    • Currency conversion rates for US$
    • Research methodology
    • List of abbreviations

Exhibits

  • 1: Key Finding 1
  • 2: Key Finding 2
  • 3: Key Finding 3
  • 4: Key Finding 5
  • 5: Key Finding 6
  • 6: Key Finding 7
  • 7: Key Finding 8
  • 8: Parent market
  • 9: Market characteristics
  • 10: Offerings of vendors included in the market definition
  • 11: Market segments
  • 12: Global - Market size and forecast 2020 - 2025 ($ million)
  • 13: Global market: Year-over-year growth 2020 - 2025 (%)
  • 14: Five forces analysis 2020 & 2025
  • 15: Bargaining power of buyers
  • 16: Bargaining power of suppliers
  • 17: Threat of new entrants
  • 18: Threat of substitutes
  • 19: Threat of rivalry
  • 20: Market condition - Five forces 2020
  • 21: Other1 - Market share 2020-2025 (%)
  • 22: Comparison by Other1
  • 23: Osteosarcoma - Market size and forecast 2020-2025 ($ million)
  • 24: Osteosarcoma - Year-over-year growth 2020-2025 (%)
  • 25: Chondrosarcoma - Market size and forecast 2020-2025 ($ million)
  • 26: Chondrosarcoma - Year-over-year growth 2020-2025 (%)
  • 27: Other bone cancers - Market size and forecast 2020-2025 ($ million)
  • 28: Other bone cancers - Year-over-year growth 2020-2025 (%)
  • 29: Market opportunity by Other1
  • 30: Customer landscape
  • 31: Market share By Geographical Landscape 2020-2025 (%)
  • 32: Geographic comparison
  • 33: North America - Market size and forecast 2020-2025 ($ million)
  • 34: North America - Year-over-year growth 2020-2025 (%)
  • 35: Europe - Market size and forecast 2020-2025 ($ million)
  • 36: Europe - Year-over-year growth 2020-2025 (%)
  • 37: Asia - Market size and forecast 2020-2025 ($ million)
  • 38: Asia - Year-over-year growth 2020-2025 (%)
  • 39: ROW - Market size and forecast 2020-2025 ($ million)
  • 40: ROW - Year-over-year growth 2020-2025 (%)
  • 41: Key leading countries
  • 42: Market opportunity By Geographical Landscape ($ million)
  • 43: Impact of drivers and challenges
  • 44: Vendor landscape
  • 45: Landscape disruption
  • 46: Industry risks
  • 47: Vendors covered
  • 48: Market positioning of vendors
  • 49: Amgen Inc. - Overview
  • 50: Amgen Inc. - Business segments
  • 51: Amgen Inc. - Key offerings
  • 52: Amgen Inc. - Key customers
  • 53: Amgen Inc. - Segment focus
  • 54: Baxter International Inc. - Overview
  • 55: Baxter International Inc. - Business segments
  • 56: Baxter International Inc. - Key offerings
  • 57: Baxter International Inc. - Key customers
  • 58: Baxter International Inc. - Segment focus
  • 59: Bayer AG - Overview
  • 60: Bayer AG - Business segments
  • 61: Bayer AG - Key offerings
  • 62: Bayer AG - Key customers
  • 63: Bayer AG - Segment focus
  • 64: Bristol-Myers Squibb Co. - Overview
  • 65: Bristol-Myers Squibb Co. - Product and service
  • 66: Bristol-Myers Squibb Co. - Key offerings
  • 67: Bristol-Myers Squibb Co. - Key customers
  • 68: Bristol-Myers Squibb Co. - Segment focus
  • 69: Eisai Co. Ltd. - Overview
  • 70: Eisai Co. Ltd. - Business segments
  • 71: Eisai Co. Ltd. - Key offerings
  • 72: Eisai Co. Ltd. - Key customers
  • 73: Eisai Co. Ltd. - Segment focus
  • 74: F. Hoffmann-La Roche Ltd. - Overview
  • 75: F. Hoffmann-La Roche Ltd. - Business segments
  • 76: F. Hoffmann-La Roche Ltd. - Key offerings
  • 77: F. Hoffmann-La Roche Ltd. - Key customers
  • 78: F. Hoffmann-La Roche Ltd. - Segment focus
  • 79: Merck and Co. Inc. - Overview
  • 80: Merck and Co. Inc. - Business segments
  • 81: Merck and Co. Inc. - Key offerings
  • 82: Merck and Co. Inc. - Key customers
  • 83: Merck and Co. Inc. - Segment focus
  • 84: Novartis AG - Overview
  • 85: Novartis AG - Business segments
  • 86: Novartis AG - Key offerings
  • 87: Novartis AG - Key customers
  • 88: Novartis AG - Segment focus
  • 89: Sun Pharmaceutical Industries Ltd. - Overview
  • 90: Sun Pharmaceutical Industries Ltd. - Business segments
  • 91: Sun Pharmaceutical Industries Ltd. - Key offerings
  • 92: Sun Pharmaceutical Industries Ltd. - Key customers
  • 93: Sun Pharmaceutical Industries Ltd. - Segment focus
  • 94: Teva Pharmaceutical Industries Ltd. - Overview
  • 95: Teva Pharmaceutical Industries Ltd. - Business segments
  • 96: Teva Pharmaceutical Industries Ltd. - Key offerings
  • 97: Teva Pharmaceutical Industries Ltd. - Key customers
  • 98: Teva Pharmaceutical Industries Ltd. - Segment focus
  • 99: Currency conversion rates for US$
  • 100: Research Methodology
  • 101: Validation techniques employed for market sizing
  • 102: Information sources
  • 103: List of abbreviations